This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Anthony, S. Articles by Vallance, P. Search for Related Content PubMed PubMed Citation Articles by Anthony, S. Articles by Vallance, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE Social Bookmarking                         What's this?

Endogenous production of nitric oxide synthase inhibitors

Centre for Clinical Pharmacology, The British Heart Foundation Laboratories, University College London, UK

James Leiper

Centre for Clinical Pharmacology, The British Heart Foundation Laboratories, University College London, UK

Patrick Vallance

Centre for Clinical Pharmacology, The British Heart Foundation Laboratories, University College London, UK

Numerous reports have indicated that the plasma concentration of endogenously produced inhibitors of nitric oxide synthase are elevated in human disease states. In this review we discuss recent advances in our understanding of the enzymes responsible for the synthesis of these inhibitors.

Key Words: asymmetric methylarginine • dimethylarginine dimethylaminohydrolase • nitric oxide synthase • protein-arginine methyltransferase

Vascular Medicine, Vol. 10, No. 1 suppl, S3-S9 (2005)
DOI: 10.1177/1358836X0501000102


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?